Results 291 to 300 of about 350,390 (302)

Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study

Applied Soft Computing Journal, 2021
Yajie Meng, Min Jin, Xianfang Tang
exaly  

Increased solitary drug use during COVID-19: An unintended consequence of social distancing

International Journal of Drug Policy, 2023
Kristin E Schneider, Sean T Allen, Saba Rouhani   +2 more
exaly  

Investigational drugs for the treatment of Covid-19

2021
openaire   +1 more source

Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions

Pharmacological Research, 2020
Charles Awortwe, Ingolf Cascorbi
exaly  

Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups

Drug Delivery, 2021
Issam K Salih, Talib M Albayati
exaly  

Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients

Allergy: European Journal of Allergy and Clinical Immunology, 2022
Yasutaka Mitamura, Daniel Schulz, NicK Li   +2 more
exaly  

Integrating heterogeneous data to facilitate COVID-19 drug repurposing

Drug Discovery Today, 2022
Lucia Prieto-Santamaría, Esther Ugarte Carro, Alejandro Rodríguez-González   +2 more
exaly  

AI-driven drug discovery: A boon against COVID-19?

AI Open, 2020
Aman Chandra Kaushik
exaly  

Application of Artificial Intelligence in COVID-19 drug repurposing

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2020
Chandana Mohanty, Swati Swayamsiddha
exaly  

<p>Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review</p>

Therapeutics and Clinical Risk Management, 2020
Parisa Ghasemiyeh, Afshin Borhani-Haghighi, Iman Karimzadeh   +2 more
exaly